Summit Therapeutics Launches $500 Million Public Offering to Accelerate Ivonescimab Development
Market Chameleon (Wed, 10-Jun 7:05 AM)
Shareholder Investigation Into Summit Therapeutics Inc. Prompts Investors to Consider Recovery Options
Market Chameleon (Mon, 4-May 11:46 AM)
Summit Therapeutics Expands Global Phase III Trials While Cash Reserves Decline Amid Strategic Pipeline Push
Market Chameleon (Fri, 1-May 7:06 AM)
